Integrated screening identifies GPR31 as a key driver and druggable target for metabolic dysfunction–associated steatohepatitis

Journal:

Journal of Clinical Investigation

Published:

2025-09-02

DOI:

10.1172/jci173193

Affiliations:

11

Authors:

30

Go to article

Institutions	Authors	Share
The First Affiliated Hospital of Gannan Medical University, China	15.833333 15.833333	0.53
Renmin Hospital of Wuhan University/Hubei General Hospital, China	3.833333	0.13
Wuhan University (WHU), China	3.500000	0.12
Zhongnan Hospital, WHU, China	2.333333	0.08
State Key Laboratory of Mechanism and Quality of Chinese Medicine, China	1.000000	0.03
Huanggang Central Hospital, China	1.000000	0.03
China Pharmaceutical University (CPU), China	1.000000	0.03
Duke-NUS Medical School, Singapore	1.000000	0.03
The Third Xiangya Hospital, CSU, China	0.500000	0.02

Interested in Medical Biochemistry and Metabolomics?